Table 1: Survey of important immunogenic peptides tested as vaccine candidates.

Virus Protein Selected Epitope (s)* Reference
Hantaan virus S segment** MRNTIMASK [39]
M segment glycoprotein AA8-AA16, VMASLVWPV,
AA358-AA366, LIWTGMIDL
AA996-AA1004, SLTECPTFL
[40]
Adenovirus 4 hexon 418-AGSEK-422, [41]
hexon SGYDPYYTY [42]
Influenza A M2 AA9-19, AA27-36 [49]
NP AA336-348, AA217-226
M1 GILGFWFTL [50]
Hepatitis E ORF2 protein AA438-IVIPHD-444, AA457-DNQH-461 [53]
AA459-606 [54]
Hepatitis A VP1 AA11-25 [55]
VP3 AA102-121
Hepatitis A
and E Combined
VP1 (from HA)
ORF2 (from HE)
AA1-198
AA368-607
[56]
Hepatitis C Gp E2 AA412-423 [57]
Hepatitis B pre-S2 AA18-24, [59]
HBcAg AA18-27
pre-S1 AA2-48 [61]
L protein GGPNLDNIL, LTTVPAASLLA [62]
S protein ILRSFIPLL, FLGGPPVCL
C protein LTFGRETVLEN
P protein FLKQQYMNL, FLSKQYMDL, TVSTKLCKI
Foot and Mouth Disease Virus (FMDV) VP1 AA135-159, AA176-189 [63]
L protein 42-TLASIGTAF-50 [65]
HIV*** gp41 MPER [68]
EBV/HHV-4**** BZLF1/Zta RAKFKQLL [70, 71]
HSV-2/HHV-2***** gB
gC
gD
gE
gG
gI
AA 466-473, AA162-177
AA216-223
AA6-18, AA21-28, AA205-224, AA245-259 AA268-276
AA483-491
AA572-579
AA286-295
[77]
gD AA53-61, AA70-78, AA49-82, AA278-286 [79, 80]
gB AA498-505 [83]
gD AA49-89
Varicella-zoster virus gE AA1-134, AA66-85, AA101-161 [84]
Cytomegalovirus pp65 AA495-503 [85, 86]
Enterovirus 71 VP1 AA211-225 [95
Lassa virus GP1 AA41-49 (SSNLYKGVY) [96]
Rabies virus glycoprotein G AA34-42, AA198-200,AA 226-264, AA 296-371, AA330-343 [97]
nucleoprotein N AA22-168, AA262-450
Poliovirus polyprotein AA465-469MMATG, AA708-712RFDME, AA752-756DYTWQT, AA763-767FYTYG, AA783-789AYSHFYD, AA835-839KIRVY, AA847-851VWCPR [101]

*the most efficient (immunogenic) peptides as described by the corresponding author (see References) ** encodes the N protein ***Human immune deficiency virus, **** Epstein-Barr virus, ***** Herpes simplex virus 2

Back to Article